Andere talen Biohaven Ltd.

Aandelen

BHVN

VGG1110E1079

slotkoers Nyse Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
38,97 ^USD	+1,12%		-0,05%	-8,95%

25/04	Biohaven Insider kocht aandelen ter waarde van $999.169, volgens een recente SEC filing	MT
23/04	Aandelen Biohaven stijgen na afsluiting openbaar aanbod, openbaarmaking aankoop aandelen door CEO	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	25/04
Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO	23/04
Biohaven Insider Bought Shares Worth $7,999,961, According to a Recent SEC Filing	23/04
Biohaven Insider Bought Shares Worth $4,999,991, According to a Recent SEC Filing	23/04
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	18/04
Biohaven Prices $230 Million Public Share Offering	18/04
Biohaven Launches $200 Million Common Stock Offering	17/04
North American Morning Briefing : Stocks Struggle After New Records	22/03
Biohaven Q4 Non-GAAP Net Loss Widens, Shares Fall After-Hours	29/02
Biohaven Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Biohaven Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Adipositas-Mittel führen zu Muskelverlust - Pharmafirmen steuern gegen	22/01
Biohaven Insider Sold Shares Worth $459,663, According to a Recent SEC Filing	02/01
Certain Common Shares of Biohaven Ltd. are subject to a Lock-Up Agreement Ending on 17-NOV-2023.	17/11
Certain Stock Options of Biohaven Ltd. are subject to a Lock-Up Agreement Ending on 17-NOV-2023.	17/11
North American Morning Briefing : Stocks Seen -2-	15/11
Biohaven Pharmaceutical Q3 Net Loss Narrows	14/11
Biohaven Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Biohaven Pharmaceutical Says Obesity Treatment Candidate Reduces Fat, Improves Lean Mass	16-10-23
Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek®	16-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biohaven Ltd.

Aandelen

BHVN

VGG1110E1079

Andere talen

Filters